Zoetis Inc. | Large-cap | Healthcare
$167.10
1.51%
| Zoetis Stock Comparison:
Zoetis vs Haleon Plc - ADRZoetis vs United TherapeuticsZoetis vs Intra-CellularZoetis vs NeurocrineZoetis vs ViatrisZoetis vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 9.3B
Gross Profit 6.5B 70.62%
Operating Income 3.4B 36.65%
Net Income 2.5B 26.97%
EPS (Diluted) $5.47

Balance Sheet Metrics

Total Assets 14.2B
Total Liabilities 9.5B
Shareholders Equity 4.8B
Debt to Equity 1.98

Cash Flow Metrics

Operating Cash Flow 2.8B
Free Cash Flow 2.3B

Revenue & Profitability Trend

Zoetis Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 9.3B 8.5B 8.1B 7.8B 6.7B
Cost of Goods Sold 2.7B 2.6B 2.5B 2.3B 2.1B
Gross Profit 6.5B 6.0B 5.6B 5.5B 4.6B
Research & Development 686.0M 614.0M 539.0M 508.0M 463.0M
Selling, General & Administrative 2.3B 2.2B 2.0B 2.0B 1.7B
Other Operating Expenses 141.0M 149.0M 150.0M 161.0M 160.0M
Total Operating Expenses 3.1B 2.9B 2.7B 2.7B 2.3B
Operating Income 3.4B 3.1B 2.9B 2.8B 2.3B
Pre-tax Income 3.1B 2.9B 2.7B 2.5B 2.0B
Income Tax 637.0M 596.0M 545.0M 454.0M 360.0M
Net Income 2.5B 2.3B 2.1B 2.0B 1.6B
EPS (Diluted) $5.47 $5.07 $4.49 $4.27 $3.42

Income Statement Trend

Zoetis Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 6.0B 6.3B 7.5B 6.9B 6.6B
Non-Current Assets 8.3B 7.9B 7.4B 7.0B 7.0B
Total Assets 14.2B 14.3B 14.9B 13.9B 13.6B
Liabilities
Current Liabilities 3.4B 1.9B 3.2B 1.8B 2.2B
Non-Current Liabilities 6.1B 7.4B 7.4B 7.6B 7.7B
Total Liabilities 9.5B 9.3B 10.5B 9.4B 9.8B
Equity
Total Shareholders Equity 4.8B 5.0B 4.4B 4.5B 3.8B

Balance Sheet Composition

Zoetis Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income 2.5B 2.3B 2.1B 2.0B 1.6B
Operating Cash Flow 2.8B 2.3B 1.7B 2.1B 2.0B
Investing Activities
Capital Expenditures - - - - -
Investing Cash Flow 340.0M -45.0M -297.0M 19.0M -119.0M
Financing Activities
Dividends Paid -786.0M -692.0M -611.0M -474.0M -380.0M
Financing Cash Flow -2.7B -3.1B -866.0M -1.8B 103.0M
Free Cash Flow 2.3B 1.6B 1.3B 1.7B 1.7B

Cash Flow Trend

Zoetis Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 28.34
Forward P/E 24.90
Price to Book 15.12
Price to Sales 7.57
PEG Ratio 24.90

Profitability Ratios

Profit Margin 27.12%
Operating Margin 38.11%
Return on Equity 52.09%
Return on Assets 15.11%

Financial Health

Current Ratio 1.74
Debt to Equity 145.63
Beta 0.94

Per Share Data

EPS (TTM) $5.57
Book Value per Share $10.44
Revenue per Share $20.56

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
zts 70.3B 28.34 15.12 52.09% 27.12% 145.63
Haleon Plc - ADR 47.2B 25.01 5.88 8.95% 12.84% 63.41
United Therapeutics 12.9B 11.41 1.90 19.94% 40.44% 2.94
Intra-Cellular 14.0B -183.15 12.20 -8.58% -10.97% 1.48
Neurocrine 12.5B 42.90 4.94 12.43% 12.68% 19.45
Viatris 10.4B 235.80 0.67 -21.25% -26.45% 92.38

Financial data is updated regularly. All figures are in the company's reporting currency.